ACTG Publications

Have the explosive HIV epidemics in sub-Saharan Africa been driven by higher community viral load?Abu-Raddad, Laith J ; Barnabas, Ruanne V ; Janes, Holly ; Weiss, Helen A ; Kublin, James G ; Longini, Ira M ; Wasserheit, Judith N ; HIV Viral Load Working Group2013 Mar 27AIDS627
Health-related quality of life in subjects with HCV/HIV coinfection: results from ACTG 5178 study.Kemmer, N ; Hua, L ; Andersen, J W ; Chung, R T ; Butt, A A ; Sherman, K E ; ACTG 5178 Study Team2012 NovJ Viral Hepat1119
Hematologic toxicity associated with interferon-based hepatitis C therapy in HIV type 1-coinfected subjects.Behler, Caroline M ; Vittinghoff, Eric ; Lin, Feng ; Chung, Raymond T ; Peters, Marion G ; Robbins, Gregory K ; Volberding, Paul A2007 May 15Clin Infect Dis1044
Hemochromatosis gene polymorphisms, mitochondrial haplogroups, and peripheral lipoatrophy during antiretroviral therapy.Hulgan, Todd ; Tebas, Pablo ; Canter, Jeffrey A ; Mulligan, Kathleen ; Haas, David W ; Dubé, Michael ; Grinspoon, Steven ; Robbins, Gregory K ; Motsinger, Alison A ; Kallianpur, Asha R ; AIDS Clinical Trials Group 384 and A5005s Study Teams2008 Mar 15J Infect Dis6197
Hemochromatosis (HFE) gene mutations and peripheral neuropathy during antiretroviral therapy.Kallianpur, Asha R ; Hulgan, Todd ; Canter, Jeffrey A ; Ritchie, Marylyn D ; Haines, Jonathan L ; Robbins, Gregory K ; Shafer, Robert W ; Clifford, David B ; Haas, David W2006 Jul 13AIDS1120
Hemodialysis does not significantly affect the pharmacokinetics of nevirapine in HIV-1-infected persons requiring hemodialysis: results from ACTG A5177.Cramer, Yoninah S ; Rosenkranz, Susan L ; Hall, Stephen D ; Szczech, Lynda A ; Amorosa, Valerianna ; Gupta, Samir K2010 AugJ Acquir Immune Defic Syndr454
Hepatitis C virus (HCV) quasispecies complexity and selection in HCV/HIV-coinfected subjects treated with interferon-based regimens.Sherman, Kenneth E ; Rouster, Susan D ; Stanford, Sandra ; Blackard, Jason T ; Shire, Norah ; Koziel, Margaret ; Peters, Marion ; Chung, Raymond T ; AIDS Clinical Trials Group 5071 Study Team2010 MarJ Infect Dis5201
Hepatitis C virus/HIV coinfection and responses to initial antiretroviral treatment.Hua, Lei ; Andersen, Janet W ; Daar, Eric S ; Glesby, Marshall J ; Hollabaugh, Kimberly ; Tierney, Camlin2013 Nov 13AIDS1727
Hepatotoxicity and gastrointestinal intolerance when healthy volunteers taking rifampin add twice-daily atazanavir and ritonavir.Haas, David W ; Koletar, Susan L ; Laughlin, Laura ; Kendall, Michelle A ; Suckow, Carol ; Gerber, John G ; Zolopa, Andrew R ; Bertz, Richard ; Child, Michael J ; Hosey, Lara ; Alston-Smith, Beverly ; Acosta, Edward P ; A5213 StudyTeam2009 Mar 1J Acquir Immune Defic Syndr350
Herpes Simplex Virus Type 2 Acquisition Among HIV-1-Infected Adults Treated With Tenofovir Disoproxyl Fumarate as Part of Combination Antiretroviral Therapy: Results From the ACTG A5175 PEARLS Study.Celum, Connie ; Hong, Ting ; Cent, Anne ; Donnell, Deborah ; Morrow, Rhoda ; Baeten, Jared M ; Firnhaber, Cynthia ; Grinsztejn, Beatriz ; Hosseinipour, Mina C ; Lalloo, Umesh ; Nyirenda, Mulinda ; Riviere, Cynthia ; Sanchez, Jorge ; Santos, Breno ; Supparatpinyo, Khuanchai ; Hakim, James ; Kumarasamy, N ; Campbell, Thomas B ; ACTG PEARLS/A2017 03 15J Infect Dis6215
Herpes simplex virus type 2 infection does not influence viral dynamics during early HIV-1 infection.Cachay, Edward R ; Frost, Simon D W ; Richman, Douglas D ; Smith, Davey M ; Little, Susan J2007 May 1J Infect Dis9195
Hidden Markov models for settings with interval-censored transition times and uncertain time origin: application to HIV genetic analyses.Healy, Brian ; Degruttola, Victor2007 AprBiostatistics28
Hierarchical Bayesian methods for estimation of parameters in a longitudinal HIV dynamic system.Huang, Yangxin ; Liu, Dacheng ; Wu, Hulin2006 JunBiometrics262
High Accuracy of Common HIV-Related Oral Disease Diagnoses by Non-Oral Health Specialists in the AIDS Clinical Trial Group.Shiboski, Caroline H ; Chen, Huichao ; Secours, Rode ; Lee, Anthony ; Webster-Cyriaque, Jennifer ; Ghannoum, Mahmoud ; Evans, Scott ; Bernard, Daphné ; Reznik, David ; Dittmer, Dirk P ; Hosey, Lara ; Severe, Patrice ; Aberg, Judith A ; Oral HIV/AIDS Research Alliance, Subcommittee of the AIDS Clinical Trial Group2015PLoS One710
High-avidity, high-IFNγ-producing CD8 T-cell responses following immune selection during HIV-1 infection.Keane, Niamh M ; Roberts, Steven G ; Almeida, Coral-Ann M ; Krishnan, Tanya ; Chopra, Abha ; Demaine, Emma ; Laird, Rebecca ; Tschochner, Monika ; Carlson, Jonathan M ; Mallal, Simon ; Heckerman, David ; James, Ian ; John, Mina2012 FebImmunol Cell Biol290
Higher expression of several interferon-stimulated genes in HIV-1-infected females after adjusting for the level of viral replication.Chang, J Judy ; Woods, Matt ; Lindsay, Robert J ; Doyle, Erin H ; Griesbeck, Morgane ; Chan, Ellen S ; Robbins, Gregory K ; Bosch, Ronald J ; Altfeld, Marcus2013 Sep 1J Infect Dis5208
High-grade anal intraepithelial neoplasia among HIV-1-infected men screening for a multicenter clinical trial of a human papillomavirus vaccine.Wilkin, Timothy ; Lee, Jeannette Y ; Lensing, Shelly Y ; Stier, Elizabeth A ; Goldstone, Stephen E ; Berry, Michael J ; Jay, Naomi ; Aboulafia, David M ; Einstein, Mark H ; Saah, Alfred ; Mitsuyasu, Ronald T ; Palefsky, Joel M2013 Mar-AprHIV Clin Trials214
High-sensitivity C-reactive protein levels do not decrease with the use of statins in all persons with HIV infection.Fichtenbaum, Carl J ; Evans, Scott E ; Aberg, Judith A2011 Oct 23AIDS1625
HIV and aging.Shah, Sanjiv ; Mildvan, Donna2006 MayCurr Infect Dis Rep38
HIV coinfection impairs CD28-mediated costimulation of hepatitis C virus-specific CD8 cells.Yonkers, Nicole L ; Rodriguez, Benigno ; Post, Anthony B ; Asaad, R ; Jones, Linda ; Lederman, Michael M ; Lehmann, Paul V ; Anthony, Donald D2006 Aug 1J Infect Dis3194
HIV drug development: the next 25 years.Flexner, Charles2007 DecNat Rev Drug Discov126
HIV escape mutations occur preferentially at HLA-binding sites of CD8 T-cell epitopes.Bronke, Corine ; Almeida, Coral-Ann M ; McKinnon, Elizabeth ; Roberts, Steven G ; Keane, Niamh M ; Chopra, Abha ; Carlson, Jonathan M ; Heckerman, David ; Mallal, Simon ; John, Mina2013 Mar 27AIDS627
HIV neuropathy natural history cohort study: assessment measures and risk factors.Simpson, D M ; Kitch, D ; Evans, S R ; McArthur, J C ; Asmuth, D M ; Cohen, B ; Goodkin, K ; Gerschenson, M ; So, Y ; Marra, C M ; Diaz-Arrastia, R ; Shriver, S ; Millar, L ; Clifford, D B ; ACTG A5117 Study Group2006 Jun 13Neurology1166
HIV peripheral neuropathy progression: protection with glucose-lowering drugs?Evans, Scott R ; Lee, Anthony J ; Ellis, Ronald J ; Chen, Huichao ; Wu, Kunling ; Bosch, Ronald J ; Clifford, David B2012 OctJ Neurovirol518
HIV Salvage Therapy Does Not Require Nucleoside Reverse Transcriptase Inhibitors: A Randomized, Controlled Trial.Tashima, Karen T ; Smeaton, Laura M ; Fichtenbaum, Carl J ; Andrade, Adriana ; Eron, Joseph J ; Gandhi, Rajesh T ; Johnson, Victoria A ; Klingman, Karin L ; Ritz, Justin ; Hodder, Sally ; Santana, Jorge L ; Wilkin, Timothy ; Haubrich, Richard H ; A5241 Study Team2015 Dec 15Ann Intern Med12163
HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients.McCutchan, J Allen ; Wu, Julia W ; Robertson, Kevin ; Koletar, Susan L ; Ellis, Ronald J ; Cohn, Susan ; Taylor, Michael ; Woods, Steven ; Heaton, Robert ; Currier, Judith ; Williams, Paige L2007 May 31AIDS921
HIV Transmission Risk Behavior in a Cohort of HIV-Infected Treatment-Naïve Men and Women in the United States.Landovitz, Raphael J ; Tran, Thuy Tien T ; Cohn, Susan E ; Ofotokun, Ighovwhera ; Godfrey, Catherine ; Kuritzkes, Daniel R ; Lennox, Jeffrey L ; Currier, Judith S ; Ribaudo, Heather J2016 Mar 16AIDS Behav
HIV-1 amino acid changes among participants with virologic failure: associations with first-line efavirenz or atazanavir plus ritonavir and disease status.Mollan, Katie ; Daar, Eric S ; Sax, Paul E ; Balamane, Maya ; Collier, Ann C ; Fischl, Margaret A ; Lalama, Christina M ; Bosch, Ronald J ; Tierney, Camlin ; Katzenstein, David ; AIDS Clinical Trials Group Study A5202 Team2012 Dec 15J Infect Dis12206
HIV-1 clinical isolates resistant to CCR5 antagonists exhibit delayed entry kinetics that are corrected in the presence of drug.Putcharoen, Opass ; Lee, Sun Hee ; Henrich, Timothy J ; Hu, Zixin ; Vanichanan, Jakapat ; Coakley, Eoin ; Greaves, Wayne ; Gulick, Roy M ; Kuritzkes, Daniel R ; Tsibris, Athe M N2012 JanJ Virol286
HIV-1 Coinfection Does Not Reduce Exposure to Rifampin, Isoniazid, and Pyrazinamide in South African Tuberculosis Outpatients.Rockwood, Neesha ; Meintjes, Graeme ; Chirehwa, Maxwell ; Wiesner, Lubbe ; McIlleron, Helen ; Wilkinson, Robert J ; Denti, Paolo2016 10Antimicrob Agents Chemother1060
HIV-1 DNA decay dynamics in blood during more than a decade of suppressive antiretroviral therapy.Besson, Guillaume J ; Lalama, Christina M ; Bosch, Ronald J ; Gandhi, Rajesh T ; Bedison, Margaret A ; Aga, Evgenia ; Riddler, Sharon A ; McMahon, Deborah K ; Hong, Feiyu ; Mellors, John W2014 Nov 1Clin Infect Dis959
HIV-1 drug resistance genotype results in patients with plasma samples with HIV-1 RNA levels less than 75 copies/mL.Mitsuya, Yumi ; Winters, Mark A ; Fessel, W Jeffrey ; Rhee, Soo-Yon ; Slome, Sally ; Flamm, Jason ; Horberg, Michael ; Hurley, Leo ; Klein, Daniel ; Shafer, Robert W2006 SepJ Acquir Immune Defic Syndr143
HIV-1 pol mutation frequency by subtype and treatment experience: extension of the HIVseq program to seven non-B subtypes.Rhee, Soo-Yon ; Kantor, Rami ; Katzenstein, David A ; Camacho, Ricardo ; Morris, Lynn ; Sirivichayakul, Sunee ; Jorgensen, Louise ; Brigido, Luis F ; Schapiro, Jonathan M ; Shafer, Robert W ; International Non Subtype B HIV-1 Working Group2006 Mar 21AIDS520
HIV-1 protease inhibitors and clinical malaria: a secondary analysis of the AIDS Clinical Trials Group A5208 study.Porter, Kimberly A ; Cole, Stephen R ; Eron, Joseph J ; Zheng, Yu ; Hughes, Michael D ; Lockman, Shahin ; Poole, Charles ; Skinner-Adams, Tina S ; Hosseinipour, Mina ; Shaffer, Doug ; D'Amico, Ronald ; Sawe, Frederick K ; Siika, Abraham ; Stringer, Elizabeth ; Currier, Judith S ; Chipato, Tsungai ; Salata, Robert ; McCarthy, James S ; Mesh2012 FebAntimicrob Agents Chemother256
HIV-1 RNA levels and antiretroviral drug resistance in blood and non-blood compartments from HIV-1-infected men and women enrolled in AIDS clinical trials group study A5077.Kantor, Rami ; Bettendorf, Daniel ; Bosch, Ronald J ; Mann, Marita ; Katzenstein, David ; Cu-Uvin, Susan ; D'Aquila, Richard ; Frenkel, Lisa ; Fiscus, Susan ; Coombs, Robert ; ACTG A5077 Study Team2014PLoS One49
HIV-1 viruses detected during episodic blips following interleukin-7 administration are similar to the viruses present before and after interleukin-7 therapy.Imamichi, Hiromi ; Degray, Gerald ; Asmuth, David M ; Fischl, Margaret A ; Landay, Alan L ; Lederman, Michael M ; Sereti, Irini2011 Jan 14AIDS225
Host gene expression changes correlating with anti-HIV-1 effects in human subjects after treatment with peginterferon Alfa-2a.Hubbard, Jonathan J ; Greenwell-Wild, Teresa ; Barrett, Lisa ; Yang, Jun ; Lempicki, Richard A ; Wahl, Sharon M ; Asmuth, David M ; Murphy, Robert L ; Pollard, Richard B ; Kottilil, Shyam2012 May 1J Infect Dis9205
Host genetic predictors of the kynurenine pathway of tryptophan catabolism among treated HIV-infected Ugandans.Lee, Sulggi A ; Mefford, Joel A ; Huang, Yong ; Witte, John S ; Martin, Jeffrey N ; Haas, David W ; McLaren, Paul J ; Mushiroda, Taisei ; Kubo, Michiaki ; Byakwaga, Helen ; Hunt, Peter W ; Kroetz, Deanna L2016 Jul 17AIDS1130
Human -defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2.Funderburg, Nicholas ; Lederman, Michael M ; Feng, Zhimin ; Drage, Michael G ; Jadlowsky, Julie ; Harding, Clifford V ; Weinberg, Aaron ; Sieg, Scott F2007 Nov 20Proc Natl Acad Sci U S A47104
Human genetic variability and HIV treatment response.Haas, David W2006 JulCurr HIV/AIDS Rep23
Human Immunodeficiency Virus-1 Sequence Changes and Drug Resistance Mutation Among Virologic Failures of Lopinavir/Ritonavir Monotherapy: AIDS Clinical Trials Group Protocol A5230.Vardhanabhuti, Saran ; Katzenstein, David ; Bartlett, John ; Kumarasamy, Nagalingeswaran ; Wallis, Carole L2016 SepOpen Forum Infect Dis33
Human papillomavirus infection in the oral cavity of HIV patients is not reduced by initiating antiretroviral therapy.Shiboski, Caroline H ; Lee, Anthony ; Chen, Huichao ; Webster-Cyriaque, Jennifer ; Seaman, Todd ; Landovitz, Raphael J ; John, Malcolm ; Reilly, Nancy ; Naini, Linda ; Palefsky, Joel ; Jacobson, Mark A2016 Jun 19AIDS1030
Hyperlipidaemia in HIV-infected patients on lopinavir/ritonavir monotherapy in resource-limited settings.Matoga, Mitch M ; Hosseinipour, Mina C ; Aga, Evgenia ; Ribaudo, Heather J ; Kumarasamy, Nagalingeswaran ; Bartlett, John ; Hughes, Michael D ; ACTG A5230 Study Team2016 Oct 14Antivir Ther